SCHAUMBURG, Ill., June 9, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leading specialty pharmaceutical company with an emphasis on the injectable market, has been ranked seventh on Crain's 2014 Fast Fifty list, published by Crain's Chicago Business. This marks the second consecutive year that Sagent has been selected as one of the leading growth companies in Chicago, topping the charts as number one in 2013. The Crain's Fast Fifty is an annual ranking that features the fastest-growing companies in Chicago.
"We are honored to be ranked among an elite group of our peers in the Chicago area. This recognition is a true testament to the proven success of our business which has enabled rapid and consistent revenue growth and has distinguished the company as a leader in Chicago," said Jeffrey Yordon, Chairman and Chief Executive Officer of Sagent Pharmaceuticals, Inc. "Our focus remains on identifying new ways to increase the breadth of our product portfolio and opportunities to innovate within the generic pharmaceutical industry. We attribute a great deal of our success to the collaborative efforts of our partners around the world, as well as to our employees' ongoing focus and commitment to the patients we serve."
As one of the fastest-growing providers of generic injectables in the U.S. market, Sagent Pharmaceuticals has a highly unique business model that combines best-in-class quality and service, an extensive global network of partners with state-of-the-art technology, and global excellence in manufacturing– including its own development and manufacturing facility in Chengdu, China. As part of its innovative approach to packaging and labeling, Sagent's PreventIV Measures SM Packaging and Labeling helps to make accurate medication selection an easy and obvious choice for caregivers. Sagent's unmatched expertise and industry-leading resources enables the company to direct and scale resources to anticipate and rapidly meet customer needs.The Crain's Fast Fifty list is an annual index of Chicago-based businesses, ranked by revenue growth over the recent five year period. Fast Fifty companies span all industries, sizes and operating models. Crain's editorial staff is responsible for determining the contents of this ranking. The 2014 Fast Fifty rankings were announced in the June 2 issue of Crain's Chicago Business. A breakfast will be held on Thursday, June 26, at the Four Seasons Hotel in Chicago, in honor of this year's top companies. To learn more about Sagent and to view the full 2014 Crain's Fast Fifty list, visit: www.chicagobusiness.com/fastfifty . About Sagent Pharmaceuticals Sagent Pharmaceuticals, Inc., founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique, global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.
CONTACT: MEDIA CONTACT: Irma Gomez-Dib firstname.lastname@example.org (212) 850-5761 INVESTOR CONTACT: Jonathon Singer email@example.com (847) 908-1605